News
We think Ingersoll Rand is on solid financial footing. The company ended 2024 with a net leverage ratio of around 1.6 times adjusted EBITDA, and debt maturities are well spread out. At the time of the ...
Achieving $1,000/month in passive income is a key goal for investors focused on yield and discipline. Check out 5 picks to ...
Our fair value estimate for KLA is $750 per share. Our valuation implies a fiscal 2026 (ending June 2026) adjusted price/earnings multiple of 21 times and a fiscal 2026 enterprise value/sales multiple ...
Boule Diagnostics (STO:BOUL) presented its Q2 2025 results on July 18, 2025, revealing a mixed performance characterized by continued sales pressure but improved cash flow.
Learn everything you need to know about key performance indicators.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results